H J Fuchs

1.0k total citations
10 papers, 789 citations indexed

About

H J Fuchs is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Infectious Diseases. According to data from OpenAlex, H J Fuchs has authored 10 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 2 papers in Immunology and 1 paper in Infectious Diseases. Recurrent topics in H J Fuchs's work include Cystic Fibrosis Research Advances (5 papers), Neonatal Respiratory Health Research (4 papers) and Inhalation and Respiratory Drug Delivery (2 papers). H J Fuchs is often cited by papers focused on Cystic Fibrosis Research Advances (5 papers), Neonatal Respiratory Health Research (4 papers) and Inhalation and Respiratory Drug Delivery (2 papers). H J Fuchs collaborates with scholars based in United States, United Kingdom and Austria. H J Fuchs's co-authors include Myron I. Cybulsky, J B Baker, Michael A. Gimbrone, E N Brunette, Judd E. Shellito, D M Geddes, David Høyrup Christiansen, Steven Shak, B Assoufi and D W Empey and has published in prestigious journals such as The Lancet, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

H J Fuchs

10 papers receiving 760 citations

Peers

H J Fuchs

PRM

IMMUN

EPIDE

MB

IA

A. Blussé van Oud Alblas Netherlands

Masayuki Nakayama Japan

Venus A. Wong United States

Michiel Heron Netherlands

André Zandvoort Netherlands

Catherine Ptaschinski United States

Nikolaus Freudenberg Germany

Vandana Pradhan India

Satoko Hojo Japan

Y Suen United States

A. Blussé van Oud Alblas Netherlands

H J Fuchs

223 ×0.6

PRM

511 ×2.4

IMMUN

179 ×1.2

EPIDE

136 ×1.2

MB

39 ×0.5

IA

Citations per year, relative to H J Fuchs H J Fuchs (= 1×) peers A. Blussé van Oud Alblas

Countries citing papers authored by H J Fuchs

Since Specialization

Citations

This map shows the geographic impact of H J Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H J Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H J Fuchs more than expected).

Fields of papers citing papers by H J Fuchs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H J Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H J Fuchs. The network helps show where H J Fuchs may publish in the future.

Co-authorship network of co-authors of H J Fuchs

This figure shows the co-authorship network connecting the top 25 collaborators of H J Fuchs. A scholar is included among the top collaborators of H J Fuchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H J Fuchs. H J Fuchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Laube, Beth L., et al.. (1996). Effect of rhDNase on Airflow Obstruction and Mucociliary Clearance in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 153(2). 752–760. 54 indexed citations

2.

Wilmott, Robert W., Raouf Amin, Andrew A. Colin, et al.. (1996). Aerosolized Recombinant Human DNase in Hospitalized Cystic Fibrosis Patients With Acute Pulmonary Exacerbations. American Journal of Respiratory and Critical Care Medicine. 153(6). 1914–1917. 49 indexed citations

3.

Shah, Pallav L., Andrew Bush, H J Fuchs, et al.. (1995). Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment. European Respiratory Journal. 8(6). 954–958. 67 indexed citations

4.

Shah, Pallav L., Sandra Scott, H J Fuchs, D M Geddes, & M.E. Hodson. (1995). Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.. Thorax. 50(4). 333–338. 40 indexed citations

5.

Ranasinha, Channa D, B Assoufi, D M Geddes, et al.. (1993). Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis. The Lancet. 342(8865). 199–202. 147 indexed citations

6.

Dünser, Martina, Bertram Häussler, H J Fuchs, & R. Margreiter. (1993). Tumorectomy plus tamoxifen for the treatment of breast cancer in the elderly.. PubMed. 19(6). 529–31. 12 indexed citations

7.

Cybulsky, Myron I., et al.. (1991). Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. The Journal of Immunology. 147(3). 883–892. 213 indexed citations

8.

Beck, James M., et al.. (1991). Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infection and Immunity. 59(11). 3859–3862. 96 indexed citations

9.

Debs, Robert J., H J Fuchs, Ramila Philip, et al.. (1990). Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats.. PubMed. 50(2). 375–80. 41 indexed citations

10.

Fuchs, H J, Ramila Philip, Anne Montgomery, et al.. (1988). Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats.. The Journal of Immunology. 140(10). 3482–3488. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact